AwesomeCapital
Monday, June 24, 2019
Conatus Phase 2b Clinical Trials in NASH Didn’t Meet Primary Endpoint
https://www.streetinsider.com/Corporate+News/Conatus+Pharmaceuticals+%28CNAT%29+ENCORE-LF+and+ENCORE-PH+Phase+2b+Clinical+Trials+in+NASH+Didnt+Meet+Primary+Endpoint/15640222.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.